ARAY - Accuray Incorporated

AI-assisted radiation therapy systems with real-time tumor tracking; revenue declined year-over-year and guidance was withdrawn due to geopolitical issues, but long-term demand remains strong.

Presenter highlights the CyberKnife AI-powered robotic radiosurgery system as a unique technology in healthcare automation, a growing long-term trend. Despite recent earnings misses, the company's transformation plan is ahead of schedule with $10M in cost improvements. Analysts see over 300% upside potential from current levels.